Aiello, Edoardo Nicolò
Mameli, Francesca
Ruggiero, Fabiana
Zirone, Eleonora
Zago, Stefano
Piacentini, Sylvie
Poletti, Barbara
Reitano, Maria Rita
Santangelo, Gabriella
Ticozzi, Nicola
Silani, Vincenzo
Priori, Alberto
Ferrucci, Roberta http://orcid.org/0000-0001-5109-9483
Funding for this research was provided by:
Ministero della Salute
Università degli Studi di Milano
Article History
Received: 22 May 2023
Accepted: 29 February 2024
First Online: 11 March 2024
Declarations
:
: V. S. received compensation for consulting services and/or speaking activities from AveXis, Cytokinetics, Italfarmaco, Liquidweb S.r.l., Novartis Pharma AG and Zambon and receives or has received research supports from the Italian Ministry of Health, AriSLA and E-Rare Joint Transnational Call. He is in the Editorial Board of <i>Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration</i>, <i>European Neurology</i>, <i>American Journal of Neurodegenerative Diseases</i>, <i>Frontiers in Neurology</i> and <i>Exploration of Neuroprotective Therapy</i>. B.P. received compensation for consulting services and/or speaking activities from Liquidweb S.r.l. B.P is the Associated Editor for <i>Frontiers in Neuroscience</i>. N. T. received compensation for consulting services from Amylyx Pharmaceuticals and Zambon Biotech SA. He is the Associate Editor for <i>Frontiers in Aging Neuroscience</i>.
: All subjects provided informed consent. The protocol and procedures were approved by the local Institutional Review Board. The procedures were conducted in accordance with the Declaration of Helsinki.